By Isaac Eliaz, MD

As independent research on low molecular weight Modified Citrus Pectin gains momentum, it’s clear that this dietary supplement is a rising star in the scientific and integrative medical communities. A large and fast-growing body of data, as well as decades of clinical use, show low molecular weight Modified Citrus Pectin effectively safeguards and elevates our most critical areas of health — from cardiovascular, liver and kidney function, to healthy cellular replication, metabolic health, nerve comfort and much more. It’s all due to low molecular weight Modified Citrus Pectin’s unique ability to bind and block rogue protein and aging biomarker, Galectin-3 (Gal-3). These studies have been done on a low molecular weight Modified Citrus Pectin that has a molecular weight under 15 kilodaltons and less than 10% degree of esterification.

Galectin-3: The Aging Biomarker

Gal-3 is rapidly gaining attention in the scientific literature as a predictive biomarker and active target for cardiovascular and cellular health, organ function and other key areas of health.  It’s a protein normally present in the body at low concentrations, but it tends to increase with age, lifestyle and other factors. When elevated in the circulation, it’s recognized as a chief culprit that accelerates the aging process and impacts organ function, cellular replication, immunity, joint mobility,  and much more. Gal-3 is easily measured with a simple blood test that’s covered by most insurance for cardiovascular screening. Integrative practitioners are also using this test to measure other areas of health — including how well their patients are aging.

What has been clearly demonstrated in the emerging research is that controlling excess Gal-3 results in significant benefits to tissues and organs, and is a critical strategy for safeguarding long-term health.  And according to the scientific literature, low molecular weight Modified Citrus Pectin – a natural Gal-3 antagonist — is the only available solution shown time and again to reach target tissues and halt the impacts of elevated Gal-3, delivering system-wide benefits for long-term health and healthy aging. This is why third-party researchers are increasingly interested in this unique nutritional supplement.*

For example, in 2016 alone, six independent studies showed low molecular weight Modified Citrus Pectin blocked Gal-3 in target tissues and as a result, actively supported key organs and systems including heart and vascular health, liver and kidney function, nerve comfort and metabolic health.*

2016 Low Molecular Weight Modified Citrus Pectin Research Highlights*  

February — Low Molecular Weight Modified Citrus Pectin blocks Gal-3 in nerve cells, supporting nerve health. Ma Z, et al. PLoS One. 2016 Feb 12;11(2):e0148792.

March — Low Molecular Weight Modified Citrus Pectin blocks Gal-3 in the left ventricle of the heart, supporting healthy cardiovascular function. Vergaro G, et al. Hypertension. 2016 Mar;67(3):606-12.

May – Low Molecular Weight Modified Citrus Pectin blocks Gal-3 in liver tissue, supporting liver health.  Abu-Elsaad NM, et al. Can J Physiol Pharmacol. 2016 May;94(5):554-62.

June – Low Molecular Weight Modified Citrus Pectin blocks Gal-3 in fatty tissue, supporting metabolic health. Martínez-Martínez E, et al. Int J Obes (Lond). 2016 Jun;40(6):1034-8.

Nov – Low Molecular Weight Modified Citrus Pectin blocks Gal-3 in heart aortic valves, supporting healthy cardiovascular function. Sadaba JR, et al. J Am Heart Assoc. 2016 Nov 4;5(11). pii: e004360.

Nov – Low Molecular Weight Modified Citrus Pectin blocks Gal-3 in two kidney tissue damage models, demonstrating support for healthy kidney function. Martinez-Martinez E, et al. PLoS One. 2016 Nov 9;11(11):e0166272.

Published clinical research also demonstrates the ability of low molecular weight Modified Citrus Pectin to safely remove heavy metals and environmental toxins, without affecting essential minerals. Low molecular weight Modified Citrus Pectin is also shown to promote a vibrant and responsive immune system by activating specific immune components and elevating their functionality. Altogether, 25 published studies spanning more than two decades establish daily use of low molecular weight Modified Citrus Pectin as a critical strategy for long-term health and healthy aging.*

Needless to say, it’s unusual for a natural compound to receive this much attention from independent, third party researchers. But low molecular weight Modified Citrus Pectin is different. As population-based studies underscore the impacts of Gal-3, we’re witnessing a paradigm shift toward integrative health, led in part by the breakthrough data showing low molecular weight Modified Citrus Pectin provides a natural and effective solution to control this rogue protein, delivering long-term benefits.*

With clinical trials in progress showing exciting preliminary results, and more research slated for 2017 and beyond, we’re confident that the body of published data will continue to deepen our understanding of low molecular weight Modified Citrus Pectin as an essential cornerstone for optimal health and longevity.*

 


Isaac Eliaz, MD is an integrative medical doctor, licensed acupuncturist, researcher, product formulator and frequent lecturer. He has been a pioneer in holistic medicine since the early 1980s, and has published numerous peer-reviewed research papers. He is founder and medical director of the Amitabha Medical Clinic in Santa Rosa, CA, an integrative center specializing in cancer, Lyme disease, and other chronic conditions. He is also the founder and chief formulator of Clinical Synergy, a company providing targeted, research based, physician-formulated nutraceuticals.


*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.